What does 2023 have in store for biotech? How can the FDA win back trust? And who came up with “XBB.1.5”?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into a sweeping congressional investigation into the FDA’s approval of the latest treatment for Alzheimer’s disease and what it means for the next one. We also preview the upcoming J.P. Morgan Healthcare Conference and the biggest biotech events of 2023.
Has your institution innovated in ways worth celebrating? Submit your application to be considered for our bracket-style tournament to find the best innovations in science and medicine here.
No comments